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Abstract
Background: Vaccination coverage rates for seasonal influenza are not meeting national and international targets. Here, we
investigated whether the 2009/2010 A/H1N1 pandemic influenza affected the uptake of influenza vaccines.
Methodology/Principal Findings: In December 2009/January 2010 and April 2010, 500 randomly selected members of the
general public in Germany, France, the United States, China, and Mexico were surveyed by telephone about vaccination for
seasonal and A/H1N1 pandemic influenza. Also, in April 2010, 100 randomly selected general practitioners were surveyed.
Adult vaccine coverage in December 2009/January 2010 for A/H1N1 pandemic and seasonal influenza were, respectively,
12% and 29% in France, 11% and 25% in Germany, 41% and 46% in the US, 13% and 30% in Mexico, and 12% and 10% in
China. Adult uptake rates in April 2010 were higher in Mexico but similar or slightly lower in the other countries. Coverage
rates in children were higher than in adults in the US, Mexico, and China but mostly lower in Germany and France. Germans
and French viewed the threat of A/H1N1 pandemic influenza as low to moderate, whereas Mexicans, Americans, and
Chinese viewed it as moderate to serious, opinions generally mirrored by general practitioners. The recommendation of a
general practitioner was a common reason for receiving the pandemic vaccine, while not feeling at risk and concerns with
vaccine safety and efficacy were common reasons for not being vaccinated. Inclusion of the A/H1N1 pandemic strain
increased willingness to be vaccinated for seasonal influenza in the United States, Mexico, and China but not in Germany or
France.
Conclusions/Significance: The 2009/2010 A/H1N1 influenza pandemic increased vaccine uptake rates for seasonal influenza
in Mexico but had little effect in other countries. Accurate communication of health information, especially by general
practitioners, is needed to improve vaccine coverage rates.
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Introduction
The World Health Organization (WHO) estimates that seasonal
influenza causes between 250,000 and 500,000 deaths worldwide
every year and costs between 1 and 6 million US dollars per
100,000 inhabitants [1]. In 2003, the WHO recommended
reaching a vaccination coverage rate (VCR) for seasonal influenza
of 75% by 2010 for high-risk populations including the elderly,
nursing-home residents, people with chronic medical conditions,
and pregnant women [2]. This target was officially adopted in
2009 by the European Union for the 2014/2015 influenza season
[3]. The WHO also recommends vaccination for seasonal health
care providers, people with essential functions in society, and
children from 6 months to 2 years of age, although they did not
provide specific VCR targets for these groups. In 2010, the US
Centers for Disease Control Prevention Advisory Committee on
Immunization Practices recommended universal influenza vacci-
nation for all persons at least 6 months of age [4]. Their objectives
for 2020 are to reach 80% vaccination coverage in children,
pregnant women, and non-institutionalized working-age adults
without high-risk conditions and 90% in institutionalized adults,
adults with high-risk conditions, the elderly, and healthcare
workers [5]. However, national recommendations as well as the
reimbursement system for influenza vaccines varied from country
to country (Table S1).
Despite the availability of safe and effective vaccines, seasonal
influenza vaccination coverage rates for at-risk patients remains
suboptimal and often far below these targets [3,6]. To reduce the
toll of the disease, vaccination campaigns must both enhance
protection in the most vulnerable individuals and increase
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e45450
acceptance in the general population. Previous surveys in Europe
and the US found that low seasonal vaccination coverage rates
(VCRs) are due to no or inadequate recommendation by general
practitioners (GPs), poor public awareness of influenza and
influenza vaccines, a lack of proactive reminder systems, and a
fear of needles [7,8,9,10].
The 2009/2010 A/H1N1 pandemic dramatically raised public
and decision-makers’ awareness of influenza. The WHO reported
more than 18,000 laboratory-confirmed deaths in 125 countries
and a rate of infection between 20% and 40% in some areas
[11,12]. In the current study, during the winter of 2009/2010, we
examined whether the A/H1N1 influenza pandemic affected
perceptions of and coverage by influenza vaccines.
Results
Survey response rates
In each country, 500 randomly selected individuals in the
general public completed telephone surveys in December 2010/
January 2011 and in April 2011. The response rates for completed
December 2009/January 2010 surveys were 11% in France, 7% in
Germany, 33% in the US, 8% in Mexico, and 7% in China. For
the April 2010 survey, the response rates were 5% in France, 5%
in Germany, 14% in the US, 6% in Mexico, and 11% in China.
Additionally, 100 GPs completed internet survey in each country
during April 2011. Response rates for completed GPs survey were
63% in France, 60% in Germany, 81% in the US, 29% in Mexico,
and 56% in China.
VCRs for A/H1N1 pandemic influenza
During December 2009/January 2010, the VCR for A/H1N1
pandemic influenza among adults was close to 10% in France,
Germany, Mexico, and China (Table 1). In the US, in contrast,
the adult vaccination rate was substantially higher, at 41%. In the
April 2010 survey, the adult VCRs were similar in all countries
except for Mexico, where it increased from 13% in December
2009/January 2010 to 31% in April 2010.
In the US, VCRs were relatively constant across age groups and
were the highest for all countries, at more than 40%. VCRs were
also relatively constant across age groups in France, although they
were all below 20%. In Germany, VCRs were also below 20% for
all age groups. In this case, they were the highest among adults 18
to 64 years of age and elderly adults but very low among children
(4%). VCRs in Mexico were the highest in elderly adults and
children and were between 13% and 28%. In China, VCRs were
highest among children (37%) but were very low in elderly adults
(8%).
For high-risk adults, approximately 2 in 5 in the US were
vaccinated for A/H1N1 pandemic influenza. In the other
countries, less than 1 in 5 high-risk adults were vaccinated for
A/H1N1 pandemic influenza.
VCRs for seasonal influenza
For seasonal influenza, the VCRs for adults in December 2009/
January 2010 ranged from 10% (China) to 46% (US) (Table 1). In
the April 2010 survey, the overall adult VCR was similar for all
countries except Mexico, where the rate increased from 30% in
Dec 2009/Jan 2010 to 46% in Apr 2010.
VCRs by age group in each country were higher for seasonal
influenza than for A/H1N1 pandemic influenza, except in China,
where the overall adult VCR for seasonal influenza remained close
to 10% (Table 1 ), and among French children, where it was 9%
(vs. 17% for A/H1N1 pandemic influenza). In France, Germany,
and the US, the VCR for seasonal influenza was highest among
Table 1. VCRs for A/H1N1 pandemic and seasonal influenza.
VCR (%)
Influenza/Age Group Period France Germany US Mexico China
A/H1N1 pandemic
All adults Dec 2009/Jan 2010 12 11 41 13 12
April 2010 11 10 39 31 10
Children Dec 2009/Jan 2010 17 4 46 24 37
Adults 18–64 y Dec 2009/Jan 2010 12 11 41 13 12
Elderly adults Dec 2009/Jan 2010 12 14 47 28 8
At-risk adults Dec 2009/Jan 2010 17 17 37 13 14
Seasonal
All adults 2007/08 26 25 46 22 11
2008/09 27 26 55 33 11
Dec 2009/Jan 2010 29 25 46 30 10
April 2010 27 27 49 44 8
Children 2007/08 6 10 32 34 26
2008/09 5 13 50 46 30
Dec 2009/Jan 2010 9 14 59 54 41
April 2010 7 12 53 62 33
Adults 18–64 y Dec 2009/Jan 2010 29 25 46 30 10
Elderly adults Dec 2009/Jan 2010 54 50 62 50 16
At-risk adults Dec 2009/Jan 2010 59 43 52 44 17
doi:10.1371/journal.pone.0045450.t001
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elderly adults, whereas in Mexico and China, the VCR was
highest among children. In the US, VCRs were relatively constant
across age groups, and in all cases, they were the highest of all five
countries examined in this survey.
At least 2 in 5 high-risk adults were vaccinated for seasonal
influenza in France, Germany, the US, and Mexico. These VCRs
were higher than for A/H1N1 pandemic influenza. In China,
approximately 1 in 5 high-risk adults received the vaccination,
similar to the rate for A/H1N1 influenza.
Between the 2007/08 and 2009/2010 influenza seasons, the
VCRs for seasonal influenza among adults remained relatively
constant in each county. Although being overall steady, the VCRs
were consistently highest in the US (46% in 2007/08 and 2009/
2010, with a peak of 55% in 2008/09) and lowest in China
(ranging from 11% to 10%) (Table 1). In contrast, VCRs among
children increased over time in all countries. The highest VCRs
for children were consistently in the US and Mexico and the
lowest in France and Germany.
Table 2. General public opinions of A/H1N1 pandemic influenza and vaccination for it.
Number of Respondents (%)
France Germany US Mexico China
What was the origin of your decision to get vaccinated for A/H1N1 flu? N = 57 N=54 N=228 N=184 N= 94
Physician’s advice or recommendation 23 (40) 23 (42) 84 (37) 61 (33) 9 (10)
Media 10 (18) 11 (21) 91 (40) 42 (23) 24 (25)
Government/health authorities 9 (15) 1 (2) 48 (21) 29 (16) 54 (57)
Family, friends, or relatives 3 (6) 6 (12) 57 (25) 26 (14) 16 (17)
School work/university organized vaccination 2 (3) 6 (11) 7 (3) 7 (4) 20 (21)
Pharmacist’s advice or recommendation 0 (0) 1 (2) 14 (6) 6 (3) 1 (1)
Own decision/personal choice 1 (2) 3 (6) 2 (1) 8 (1) 0 (0)
Othera 17 (29) 12 (22) 41 (18) 28 (15) 2 (2)
How much of a threat do you consider the severity of the
A/H1N1 flu to yourself?b
N = 500 N=500 N=500 N=495 N= 500
Mild (score = 0 to 2), n (%) 155 (31) 160 (32) 90 (18) 30 (6) 85 (17)
Moderate (score = 3 to 7), n (%) 300 (60) 315 (63) 315 (63) 213 (43) 285 (57)
Serious (score = 8 to 10), n (%) 45 (9) 25 (5) 95 (19) 252 (51) 130 (26)
Mean score 4.0 3.5 5.0 6.9 5.2
How much of a threat do you consider the risk of catching the
A/H1N1 flu to yourself?b
N = 500 N=500 N=500 N=495 N= 500
Mild (score = 0 to 2), n (%) 160 (32) 195 (39) 95 (19) 45 (9) 120 (24)
Moderate (score = 3 to 7), n (%) 290 (58) 285 (57) 310 (62) 277 (56) 305 (61)
Serious (score = 8 to 10), n (%) 50 (10) 20 (4) 95 (19) 173 (35) 75 (15)
Mean score 4.0 3.2 4.9 6.1 4.5
How much of a threat do you consider the severity of the
A/H1N1 flu to your children?b
N = 139 N=166 N=175 N=152 N= 139
Mild (score = 0 to 2), n (%) 40 (29) 48 (29) 24 (14) 11 (7) 15 (11)
Moderate (score = 3 to 7), n (%) 81 (58) 106 (64) 91 (52) 65 (43) 81 (58)
Serious (score = 8 to 10), n (%) 18 (13) 12 (7) 60 (34) 76 (50) 43 (31)
Mean score 4.2 4.0 5.8 7.0 5.9
How much of a threat do you consider the risk of catching
the A/H1N1 flu to your children?b
N = 139 N=166 N=175 N=152 N= 139
Mild (score = 0 to 2), n (%) 42 (30) 52 (31) 21 (12) 14 (9) 19 (14)
Moderate (score = 3 to 7), n (%) 74 (53) 101 (61) 105 (60) 82 (54) 81 (58)
Serious (score = 8 to 10), n (%) 24 (17) 13 (8) 49 (28) 56 (37) 39 (28)
Mean score 4.4 3.8 5.7 6.3 5.5
How do you perceive the media’s coverage of the A/H1N1 flu? N = 500 N=500 N=500 N=495 N= 500
Underestimates the seriousness 10 (2) 5 (1) 50 (10) 59 (12) 75 (15)
Correctly conveys the seriousness 80 (16) 115 (23) 255 (51) 208 (42) 350 (70)
Overestimates the seriousness 410 (82) 380 (76) 195 (39) 228 (46) 75 (15)
All values are n (%).
aMost common ‘‘other’’ reasons were: at risk/chronic health condition (all countries), for protection/prevention/worried about getting sick (France, Germany, US, and
Mexico), and free/available (China).
bResponses were on a scale of 0 (no threat) to 10 (serious threat).
doi:10.1371/journal.pone.0045450.t002
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Opinions of the general public about the 2009/2010 A/
H1N1 pandemic influenza and drivers for and against
vaccination
In France, Germany, and Mexico, the most common reason to
be vaccinated for A/H1N1 pandemic influenza was a physician’s
advice or recommendation (Table 2). In the US, media advertising
was the most important motivating factor, although a physician’s
advice was nearly as important. Motivations in China were distinct
from other countries, with the most important reason for
vaccination being instructions by government or health authori-
ties, followed by media advertising.
In France, the US, and China, the largest difference of opinion
between those vaccinated and not vaccinated for A/H1N1
pandemic influenza was that the latter felt they were healthy
and therefore did not need the vaccination (Figure 1). In Germany
and Mexico, the major difference lies on the fact that several
patients followed physicians’ recommendation. This trend was also
observed in the US and in France, but appeared as the second
major difference. On the other side, key factors motivating
respondents to not be vaccinated included the followings: lack of
trust in vaccines (France, China), fear of adverse reactions or pain
(France, China), and concerns with cost (US, China). Additionally,
confidence in the vaccine’s efficacy (France, Germany, Mexico)
and concerns of contracting A/H1N1 influenza (US, Mexico) also
appeared to be of key importance for ‘‘not vaccinated’’ group.
General public respondents were asked to rate the threat posed
by A/H1N1 and seasonal influenza on a scale from 0 (for not a
threat) to 10 (for a serious threat). More than 90% of respondents
in France, Germany considered the threat posed by the severity of
A/H1N1 pandemic influenza to be mild or moderate (mean score
,5 in both countries) (Table 2). Most respondents in the US (81%)
and China (74%) also considered this threat to be mild to
moderate (mean scores #4). In Mexico, in contrast, just over half
(51%) of the respondents considered this threat to be severe (mean
score = 6.9). Patterns were similar for the threat posed by the risk
of catching A/H1N1 pandemic influenza, but mean scores were
slightly lower. Results were also very similar when parents were
asked about the threat posed to their children by A/H1N1
pandemic influenza, although scores were higher than among
adults. In summary, respondents in France and Germany tended
Figure 1. Top five difference in opinions between people vaccinated and unvaccinated for A/H1N1 pandemic influenza. General
public respondents (n = 500 per country) were asked to score between 0 (totally disagree) to 10 (totally agree) with the following statements: ‘‘In
most cases, A/H1N1 flu is a mild disease’’, ‘‘The A/H1N1 flu vaccine works well/is efficacious’’, ‘‘A/H1N1 flu vaccine is not necessary since there are
effective medications to treat the A/H1N1 flu’’, ‘‘The A/H1N1 flu vaccination is recommended by my physician’’, ‘‘I am afraid of serious adverse
reactions with A/H1N1 flu vaccine’’, ‘‘A/H1N1 flu can send me to hospital’’, ‘‘A/H1N1 flu vaccine is painful’’, ‘‘I do not trust vaccines’’, ‘‘The risk that I
contract A/H1N1 flu is high’’, ‘‘The A/H1N1 flu virus is mutating’’, ‘‘The A/H1N1 flu vaccination is recommended by the government’’, ‘‘I am healthy, I
don’t need it’’, ‘‘It takes too much time/too complicated to get vaccinated’’, ‘‘It is too expensive to get vaccinated’’, ‘‘The number of A/H1N1 flu cases
continues to rise dramatically’’, ‘‘A/H1N1 flu complications are more severe in children than for adults’’, ‘‘I would be much less likely to obtain a A/
H1N1 flu vaccine if I had to pay out of pocket for the vaccine (no insurance/insurance does not cover)’’, ‘‘I am confident with adjuvanted vaccine’’, ‘‘I
trust in the efficacy of vaccines’’. Shown are the mean scores for the top five differences between vaccinated and unvaccinated individuals.
doi:10.1371/journal.pone.0045450.g001
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to consider the risks associated with A/H1N1 influenza to be
moderate or low, those in the US and China considered them to
be moderate, and in Mexico, they considered risks to be moderate
to high. Also, the threat was perceived somewhat higher for
children than for adults.
Opinions of the general public about being vaccinated
for seasonal influenza the next year
Most respondents in France (56%) and Germany (62%)
specified that they would probably not or definitely not be
vaccinated for seasonal influenza the following year (2010/2011
influenza season), and few (30% in France and 28% in Germany)
said that they would probably or definitely be vaccinated (Table 3).
In the US and Mexico, in contrast, there are more respondents
stating that they would probably or definitely be vaccinated than
those who declared they would definitely not or probably not do so
(48% vs. 27% in the US and 67% vs. 24% in Mexico). In China,
the tendency is balanced as there are similar numbers of
respondents for or against upcoming vaccination (40% would
probably or definitely be vaccinated vs. 37% who would probably
or definitely not be vaccinated.
Most respondents in the US (61%), Mexico (82%), and China
(69%) were probably or definitely going to have their children
vaccinated, and relatively few (20%, 13%, and 19%, respectively)
were definitely not or probably not. In contrast, most respondents
in France (77%) and Germany (66%) were definitely not or
probably not planning to have their children vaccinated the next
year, while relatively few (14% in France and 20% in Germany)
were definitely or probably going to have their children
vaccinated.
GP opinions of the threat posed by A/H1N1 influenza
Like the general public, GPs were asked to rate the threat posed
by A/H1N1 and seasonal influenza on a scale from 0 (for not a
threat) to 10 (for a serious threat). Most GPs in France (83%) and
Germany (81%) considered the severity of A/H1N1 pandemic
influenza to pose a mild to moderate threat to adults (mean scores
,5) (Table 4). In the US and China, roughly similar numbers
considered the threat to be moderate or serious (mean scores ,7).
In Mexico, most of them (71%) considered the threat to be serious
(mean score = 8.1). In all surveyed countries, the threat posed by
the risk of catching A/H1N1 was considered moderate by most
respondents (mean scores 5.4 to 6.3). Results were similar when
parents were asked about the threat posed by A/H1N1 pandemic
influenza to their children. In summary, GPs in France and
Germany tended to consider the threat posed to both adults and
children by A/H1N1 pandemic and seasonal influenza as
moderate, those in the US and China tended to consider the
threat as moderate to severe, while GPs in Mexico tended to be
more concerned about the threat they consider as severe.
Opinions of the general public towards the media during
the 2009/2010 A/H1N1 influenza pandemic
Most respondents in France (82%) and Germany (76%)
considered that the media overestimated the seriousness of the
A/H1N1 influenza pandemic (Table 2). In contrast, most
respondents and China (70%) considered that the media correctly
conveyed its seriousness. In the US, the situation appeared to be
somewhat contrasted. More than half (51%) stated that the media
correctly conveyed its seriousness,while nearly two in five felt that
they overestimated its seriousness. This contrasted trend is also
observed in Mexico, where similar numbers felt that the media
correctly conveyed (42%) and overestimated its seriousness (46%).
Discussion
This survey examined influenza vaccination behaviors during
the 2009/2010 A/H1N1 pandemic influenza. The study showed
that 2009/2010 A/H1N1 pandemic had little effect on the uptake
of the seasonal influenza vaccine, except in Mexico where it
appeared to increase vaccine uptake.
In agreement with other surveys [13,14,15], VCRs in French
and German adults for both seasonal and pandemic A/H1N1
influenza were around 10% in 2009/2010. Uptake of the seasonal
influenza vaccine changed little between 2007 and 2010. As
reported elsewhere [14,16], in France, uptake of influenza
vaccines and intent to vaccinate in the future was slightly better
in children than adults but still remained poor. In Germany,
Table 3. General public opinions about seasonal influenza.
Number of Respondents (%)
France Germany US Mexico China
How likely are you to get a seasonal flu vaccine in
the 2010/2011 season?
N = 500 N= 500 N=500 N= 495 N=500
Definitely won’t 210 (42) 220 (44) 75 (15) 74 (15) 100 (20)
Probably won’t 70 (14) 90 (18) 60 (12) 45 (9) 85 (17)
Undecided 70 (14) 50 (10) 125 (25) 45 (9) 115 (23)
Probably will 35 (7) 35 (7) 125 (25) 153 (31) 165 (33)
Definitely will 115 (23) 105 (21) 115 (23) 178 (36) 35 (7)
How likely are you to seek a seasonal flu vaccine for
your child in the 2010/2011 season?
N = 144 N= 166 N=186 N= 158 N=146
Definitely won’t 78 (54) 75 (45) 20 (11) 11 (7) 18 (12)
Probably won’t 33 (23) 35 (21) 17 (9) 9 (6) 10 (7)
Undecided 13 (9) 23 (14) 35 (19) 8 (5) 17 (12)
Probably will 10 (7) 17 (10) 45 (24) 38 (24) 57 (39)
Definitely will 10 (7) 17 (10) 69 (37) 92 (58) 44 (30)
doi:10.1371/journal.pone.0045450.t003
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uptake was even lower than in France, especially in children. In
both France and Germany, uptake of the seasonal influenza
vaccine appears to have decreased during the course of the A/
H1N1 pandemic, possibly because of a negative impact of the
media. Moreover, as reported in other surveys [10,17], a
physician’s advice played a major role in the decision to be
vaccinated in France and Germany, although the ambivalence of
French and German physicians about the vaccines might have
been transmitted to their patients. Generally, French and
Germans do not seem to consider the benefits of influenza
vaccination worth their perceived risks.
In China, VCRs for adults were consistently the lowest at
approximately 10%, and they did not increase between 2007 and
2010. Vaccine uptake was better in children, and parents seemed
to becoming more concerned with the threat posed by influenza to
children. Lack of accurate communication of influenza-related
health information seems to be the main reason for the low uptake
of influenza vaccines in China. In particular, Chinese often
considered themselves not at risk to be infected with influenza, or
they were concerned about potential side-effects of vaccination.
Finally, the 2009/2010 A/H1N1 pandemic had little or no effect
on the general Chinese public’s attitude towards influenza and
influenza vaccination.
VCRs in adults for seasonal influenza were substantially higher
in Mexico than in Germany, France, and China. Uptake of the A/
H1N1 pandemic influenza vaccine was in December/January but
increased by nearly 20% by the April survey. In general, Mexicans
were very concerned by the threat posed by A/H1N1 pandemic
influenza themselves, and even more so, they were concerned
about the threat to their children. This concern appeared to have a
positive effect on vaccine uptake. Also, the media, government,
and GPs in Mexico appear to have been effective at conveying the
seriousness of A/H1N1 pandemic and seasonal influenza.
VCRs for adults in the US were the highest for all countries for
almost all categories. VCRs did not change substantially between
2007 and 2010 or between the December/January and April
surveys. Vaccination for children, however, appeared to have
become more important between 2007 and 2010. As in France
and Germany, GPs in the US play a major role in the decision to
be vaccinated, although the media may be even more important.
Despite this, about half of Americans seem to resist or not bother
being vaccinated and to have a negative or ambivalent opinion
about vaccination for influenza. The A/H1N1 pandemic did
appear to affect attitudes towards seasonal influenza vaccine in the
US.
As found in other studies [18], VCRs in this survey were
generally well below the WHO and US targets. VCRs for seasonal
influenza in elderly and at-risk adults, where targets are at least
75% coverage [2], were between 43% and 62% in France,
Germany, the US, and Mexico and only 16% or 17% in China.
The WHO does not currently have targets for other groups,
although in the US, 2010 recommendations were for universal
vaccination, and targets for 2020 were at least 80% coverage in all
groups [5]. Therefore, in all countries included in this survey,
Table 4. GP opinions about A/H1N1 pandemic influenza.
Number of Respondents (%)a
France Germany US Mexico China
How much of a threat do you consider the severity of
the A/H1N1 flu to adults?
Mild (score = 0 to 2), n (%) 12 (12) 18 (18) 3 (3) 1 (1) 5 (5)
Moderate (score = 3 to 7), n (%) 71 (71) 63 (63) 55 (55) 28 (28) 49 (49)
Serious (score = 8 to 10), n (%) 17 (17) 19 (19) 42 (42) 71 (71) 46 (46)
Mean score 5.2 5.1 6.9 8.1 7.0
How much of a threat do you consider the risk of catching
the A/H1N1 flu to adults?
Mild (score = 0 to 2), n (%) 1 (1) 4 (4) 2 (2) 7 (7) 10 (10)
Moderate (score = 3 to 7), n (%) 87 (87) 68 (68) 75 (75) 65 (65) 70 (70)
Serious (score = 8 to 10), n (%) 12 (12) 23 (23) 23 (23) 28 (28) 20 (20)
Mean score 5.6 6.3 6.3 6.0 5.4
How much of a threat do you consider the severity of the
A/H1N1 flu to children?
Mild (score = 0 to 2), n (%) 11 (11) 17 (17) 3 (3) 3 (3) 3 (3)
Moderate (score = 3 to 7), n (%) 74 (74) 62 (62) 46 (46) 27 (27) 42 (42)
Serious (score = 8 to 10), n (%) 15 (15) 21 (21) 51 (51) 70 (70) 55 (55)
Mean score 5.4 5.4 7.3 8.0 7.4
How much of a threat do you consider the risk of catching
the A/H1N1 flu to children?
Mild (score = 0 to 2), n (%) 13 (13) 4 (4) 2 (2) 6 (6) 5 (5)
Moderate (score = 3 to 7), n (%) 84 (84) 72 (72) 73 (73) 53 (53) 55 (55)
Serious (score = 8 to 10), n (%) 3 (3) 24 (24) 25 (25) 41 (41) 40 (40)
Mean score 4.4 5.8 6.4 6.7 6.6
Responses were on a scale of 0 (no threat) to 10 (serious threat).
aN = 100 for all countries and all questions.
doi:10.1371/journal.pone.0045450.t004
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substantial efforts are still needed to reach the WHO and US
targets. As found previously [18], improved or more coherent
government policies and information campaigns could have a
substantial effect on VCRs for influenza. In addition to that,
external factors such as vaccine availability and ease to access
might have a further impact on the vaccine up-take rates of
influenza vaccine.
The A/H1N1 pandemic influenza appeared to increase uptake
of the vaccine seasonal influenza in Mexico during 2009/2010. It
has been shown, that governmental actions (such as mandatory
school closure, or contain non-essential business travel) and
community mitigation efforts appealing for covering sneezes,
using facemasks, or social distancing initiated by the Mexican
Authorities reached the majority of the population living inside
and outside of Mexico city [19]. Nevertheless, confusion about
information transmitted and economic barriers has also lead to
inappropriate adoption of these mitigation actions. However, the
immense media reports stoking fear and uncertainty about
virulence and transmissibility of the virus might be one particular
reason for the enhanced vaccine uptake rate seen in this country
[20,21]. Hence, it is not surprising that Mexicans tended to
consider the A/H1N1 pandemic influenza a serious threat.
Accordingly, many Mexicans said that inclusion of the A/H1N1
pandemic strain in the seasonal influenza vaccine would increase
their willingness to be vaccinated in 2010/2011.
In contrast, in Germany, France, the US, and China, VCRs
changed little between the two surveys, although they were initially
higher for children in 2009/2010 than in 2008/2009, suggesting
an initial effect on the uptake of seasonal influenza vaccine that
was lost as the season progressed. As found in other studies
[22,23,24,25,26], previous vaccination behavior appeared to be a
more important factor than the A/H1N1 influenza pandemic in
determining vaccination behavior.
The results of this study should be considered in light of certain
limitations. All geographical areas were covered in the US, France,
and Germany, but only the three largest cities were included in
China and Mexico. Therefore, the VCRs in the latter two
countries may be overestimated because the populations surveyed
might have had easier access to the vaccines due to higher income
and more local medical centers. The study may also be limited by
the fact that the survey included only 500 people and 100 GPs in
each country. This could result in different results than in other
larger surveys or observational databases. Although the final
sample was fully representative of the respective population (in
terms of age, gender and region), selection bias due to the low
response rates especially in Germany, China and Mexico can not
be entirely ruled out. Also, the VCRs measured here are only as
accurate as the respondents’ recollection and honesty, and
opinions could also have been influenced by the fact that the
respondents were aware that they being surveyed. Indeed, VCRs
in the current survey were somewhat higher than published by the
US Centers for Disease Control [6] and lower than reported in
Mexico [27]. However, VCRs in France and Germany were in
line with previous reports [13,14,15].
This study confirmed that in all countries, GPs play a critical
role in transmitting information about influenza and the impor-
tance of vaccination [9,10,17,28]. The public appeared to
generally trust and follow the advice of their GPs, both to be or
to not be vaccinated, and public opinion usually mirrored GP
opinion. The study also confirmed an important role for the media
in the decision to be vaccinated [29,30,31], with a positive role in
the US, Mexico, and China and a possible negative role in
Germany and France. More effective, accurate, and consistent
communication of health information by GPs, the media, and
health authorities is needed in all countries to improve the uptake
of influenza vaccines. Finally, the study showed that the A/H1N1
influenza pandemic had little effect on the uptake of seasonal
influenza vaccines.
Materials and Methods
Study design
This was an international survey on the perceptions of seasonal
influenza and seasonal influenza vaccination by adults ($18 years
of age) in the general public and GPs. The survey was performed
in two parts: a first cross-sectional survey of the general public
completed between December 10, 2009 and January 23, 2010
(December 2010/January 2011 survey) and a second cross-
sectional survey of the general public and GPs completed between
April 5 and April 23, 2010 (April 2011 survey). In order to have a
global view of the study questions, surveys were carried out in all
areas of France, Germany, and the US; in Mexico City, Ecatepec,
and Guadalajara, Mexico; and in Shanghai, Beijing, and
Guangzho, China.
All respondents gave agreement and explicit oral consent at the
beginning of interviews to be included in the survey. During the
interviews, a pre-defined script with the survey’s purpose was used.
The respondents had to give their consent which was documented
by answering to the question ‘‘do you agree with the terms of this
study and proceed with the study: yes/no’’. Physicians gave their
consent via the answer on the agreement question asked on the
survey link (‘‘Are you willing to take part in this study and provide
answers for all questions that would be asked to you?’’). All
respondents were clearly informed that their answers would be
aggregated and the aggregated results were solely intent for all
types of research purposes. Both respondents and surveyors
remained anonymous.
According to the guidelines of the Esomar World research codes
and the European Pharmaceutical Market Research Association
(EphMRA) this type of study is considered market research with
no intervention and does not require the approval of an ethics
committee, as this survey is a research in people, who are deemed
healthy and not in the medical system [32,33,34]. In addition, all
fieldwork was carried out by adhering to the Safe Harbor Privacy
Principles of notice, choice, onward transfer, security, data
integrity, access, and enforcement [35].
Surveys
Members of the general public in each country were contacted
by telephone on weekdays between 16:00 and 21:00 and on
weekends between 10:00 and 18:00. Phone numbers were selected
by random digit dialing, and surveys were made using a computer-
assisted telephone interviewing system [36]. The first adult ($18
years of age) in the household who picked up the telephone call
became the person eligible for the interview. For each country,
telephone contacts were continued until 400 completed surveys
were collected from adults 18 to 64 years of age and 100
completed surveys were collected from elderly adults ($65 years of
age).
The general public surveys collected vaccination status and
opinions about the A/H1N1 pandemic and seasonal influenza
(such as on the disease severity, threat or risk to catch influenza for
both adults and children) and about influenza vaccination in the
seasons 2009/10, as well as the vaccine status of the seasons before
(2007/08 and 2008/09). Responses on opinions were on a scale of
0 (no threat) to 10 (serious threat).
General or family practitioners in each country were randomly
selected at their place of work by random digit dialing to
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participate in a computer-assisted web interview. GPs had to be
performing vaccination for seasonal influenza. They were exclud-
ed from the study if practicing for less than 3 or more than 30
years. The GP surveys collected opinions about A/H1N1
pandemic and seasonal influenza and about influenza vaccination.
For both surveys, to reduce bias, the order of possible responses
to multiple-choice questions were randomized (for two possible
responses) or rotated (for more than two possible responses).
Questionnaires were translated into the appropriate language for
each country. Questionnaires were validated in three pilot
interviews carried out in the US.
Statistical analysis and considerations
Only descriptive analysis was performed. All analysis was
performed using SPSS, version 16.0 (IBM, Armonk, NY). General
public survey results were weighted to correct for sex ratio, age,
and region of each country when differences were .3%.
Weighting was not performed for the GP survey results.
Supporting Information
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